AVCNF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
23.02M
BSPK
Price
$0.18
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
2.06M
Interact to see
Advertisement

AVCNF vs BSPK

Header iconAVCNF vs BSPK Comparison
Open Charts AVCNF vs BSPKBanner chart's image
Avicanna
Price$0.20
Change-$0.00 (-0.00%)
Volume$213.5K
Capitalization23.02M
Bespoke Extracts
Price$0.18
Change-$0.00 (-0.00%)
Volume$2.66K
Capitalization2.06M
AVCNF vs BSPK Comparison Chart in %
Loading...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCNF vs. BSPK commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and BSPK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AVCNF: $0.20 vs. BSPK: $0.19)
Brand notoriety: AVCNF and BSPK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVCNF: 270% vs. BSPK: 6%
Market capitalization -- AVCNF: $23.02M vs. BSPK: $2.06M
AVCNF [@Pharmaceuticals: Generic] is valued at $23.02M. BSPK’s [@Pharmaceuticals: Generic] market capitalization is $2.06M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whileBSPK’s FA Score has 0 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • BSPK’s FA Score: 0 green, 5 red.
According to our system of comparison, BSPK is a better buy in the long-term than AVCNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCNF’s TA Score shows that 3 TA indicator(s) are bullish while BSPK’s TA Score has 5 bullish TA indicator(s).

  • AVCNF’s TA Score: 3 bullish, 5 bearish.
  • BSPK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BSPK is a better buy in the short-term than AVCNF.

Price Growth

AVCNF (@Pharmaceuticals: Generic) experienced а -1.02% price change this week, while BSPK (@Pharmaceuticals: Generic) price change was -5.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCNF($23M) has a higher market cap than BSPK($2.06M). BSPK YTD gains are higher at: 204.276 vs. AVCNF (-2.193). BSPK has higher annual earnings (EBITDA): -1M vs. AVCNF (-1.47M). AVCNF has more cash in the bank: 457K vs. BSPK (21.4K). AVCNF has less debt than BSPK: AVCNF (73.5K) vs BSPK (1.16M). AVCNF has higher revenues than BSPK: AVCNF (25.3M) vs BSPK (1.08M).
AVCNFBSPKAVCNF / BSPK
Capitalization23M2.06M1,115%
EBITDA-1.47M-1M146%
Gain YTD-2.193204.276-1%
P/E RatioN/AN/A-
Revenue25.3M1.08M2,343%
Total Cash457K21.4K2,136%
Total Debt73.5K1.16M6%
FUNDAMENTALS RATINGS
AVCNF vs BSPK: Fundamental Ratings
AVCNF
BSPK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVCNF's Valuation (64) in the null industry is in the same range as BSPK (96). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's SMR Rating (100) in the null industry is in the same range as BSPK (100). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

BSPK's Price Growth Rating (38) in the null industry is in the same range as AVCNF (63). This means that BSPK’s stock grew similarly to AVCNF’s over the last 12 months.

BSPK's P/E Growth Rating (100) in the null industry is in the same range as AVCNF (100). This means that BSPK’s stock grew similarly to AVCNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVCNFBSPK
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRTN0.050.01
+15.85%
Fortran Corp.
CBDBY0.670.02
+2.38%
Companhia Brasileira de Distribuicao
TLSNY7.600.08
+1.06%
Telia Company AB
HPHTF11.39N/A
N/A
Hamamatsu Photonics
LEMIF0.14-0.01
-4.80%
Leading Edge Materials Corp.

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and FLGC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and FLGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+0.48%
FLGC - AVCNF
23%
Poorly correlated
+2.69%
ARSUF - AVCNF
11%
Poorly correlated
N/A
BIOYF - AVCNF
9%
Poorly correlated
-1.39%
BSPK - AVCNF
5%
Poorly correlated
-5.08%
BKUH - AVCNF
0%
Poorly correlated
N/A
More

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and OVATF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
-5.08%
OVATF - BSPK
21%
Poorly correlated
N/A
BKUH - BSPK
8%
Poorly correlated
N/A
AVCNF - BSPK
5%
Poorly correlated
+0.48%
CANN - BSPK
4%
Poorly correlated
-8.42%
CAIHF - BSPK
2%
Poorly correlated
N/A
More